Fast Growth in Real and “Virtual” Biobanks May be Revenue Opportunity for Clinical Pathology Laboratories

Biobanking is now a $7.9 billion industry and demand for specimens is skyrocketing Biobanking is going big time! VisionGain estimates that biobanking is now a $7.9 billion industry. That’s a revenue number that should interest pathologists and clinical laboratory managers, since their organizations access large volumes of patient specimens every year. As one source of human specimens, both clinical laboratories and anatomic pathology groups have an opportunity to participate in biobanking...